Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Molecular Biology

Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the Diogenes study and the Maastricht Study

International Journal of Obesity volume 44, pages 1376–1386 (2020)Cite this article

Subjects

Abstract

Background

Recent evidence indicates that insulin resistance (IR) in obesity may develop independently in different organs, representing different etiologies toward type 2 diabetes and other cardiometabolic diseases. The aim of this study was to investigate whether IR in the liver and IR in skeletal muscle are associated with distinct metabolic profiles.

Methods

This study includes baseline data from 634 adults with overweight or obesity (BMI ≥ 27 kg/m2) (≤65 years; 63% women) without diabetes of the European Diogenes Study. Hepatic insulin resistance index (HIRI) and muscle insulin sensitivity index (MISI), were derived from a five-point OGTT. At baseline 17 serum metabolites were identified and quantified by nuclear-magnetic-resonance spectroscopy. Linear mixed model analyses (adjusting for center, sex, body mass index (BMI), waist-to-hip ratio) were used to associate HIRI and MISI with these metabolites. In an independent sample of 540 participants without diabetes (BMI ≥ 27 kg/m2; 40–65 years; 46% women) of the Maastricht Study, an observational prospective population-based cohort study, 11 plasma metabolites and a seven-point OGTT were available for validation.

Results

Both HIRI and MISI were associated with higher levels of valine, isoleucine, oxo-isovaleric acid, alanine, lactate, and triglycerides, and lower levels of glycine (all p < 0.05). HIRI was also associated with higher levels of leucine, hydroxyisobutyrate, tyrosine, proline, creatine, and n-acetyl and lower levels of acetoacetate and 3-OH-butyrate (all p < 0.05). Except for valine, these results were replicated for all available metabolites in the Maastricht Study.

Conclusions

In persons with obesity without diabetes, both liver and muscle IR show a circulating metabolic profile of elevated (branched-chain) amino acids, lactate, and triglycerides, and lower glycine levels, but only liver IR associates with lower ketone body levels and elevated ketogenic amino acids in circulation, suggestive of decreased ketogenesis. This knowledge might enhance developments of more targeted tissue-specific interventions to prevent progression to more severe disease stages.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Standardized beta’s (95% CI) of associations between HIRI and metabolites.
Fig. 2: Standardized beta’s (95% CI) of associations between MISI and metabolites.

Similar content being viewed by others

References

  1. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32:1431–7.

    Article  CAS  Google Scholar 

  2. Hruby A, Manson JE, Qi L, Malik VS, Rimm EB, Sun Q, et al. Determinants and consequences of obesity. Am J Public Health. 2016;106:1656–62.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes. 2011;35:971–81.

    Article  CAS  Google Scholar 

  4. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–6.

    Article  CAS  PubMed  Google Scholar 

  5. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371:1131–41.

    Article  PubMed  CAS  Google Scholar 

  6. Stinkens R, Goossens GH, Jocken JW, Blaak EE. Targeting fatty acid metabolism to improve glucose metabolism. Obes Rev. 2015;16:715–57.

    Article  CAS  PubMed  Google Scholar 

  7. Rask-Madsen C, Kahn CR. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2012;32:2052–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yu H, Zhou D, Jia W, Guo Z. Locating the source of hyperglycemia: liver versus muscle. J Diabetes. 2012;4:30–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zheng J, Woo SL, Hu X, Botchlett R, Chen L, Huo Y, et al. Metformin and metabolic diseases: a focus on hepatic aspects. Front Med. 2015;9:173–86.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Blanco-Rojo R, Alcala-Diaz JF, Wopereis S, Perez-Martinez P, Quintana-Navarro GM, Marin C, et al. The insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: the CORDIOPREV-DIAB randomised clinical trial. Diabetologia. 2016;59:67−76.

    Article  PubMed  CAS  Google Scholar 

  11. Otten J, Stomby A, Waling M, Isaksson A, Soderstrom I, Ryberg M, et al. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial. Diabetologia. 2018;61:1548–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Klein MS, Shearer J. Metabolomics and type 2 diabetes: translating basic research into clinical application. J Diabetes Res. 2016;2016:3898502.

    Article  PubMed  CAS  Google Scholar 

  13. Pallares-Mendez R, Aguilar-Salinas CA, Cruz-Bautista I, Del Bosque-Plata L. Metabolomics in diabetes, a review. Ann Med. 2016;48:89–102.

    Article  CAS  PubMed  Google Scholar 

  14. Palmer ND, Okut H, Hsu FC, Ng MCY, Chen YI, Goodarzi MO, et al. Metabolomics identifies distinctive metabolite signatures for measures of glucose homeostasis: the Insulin Resistance Atherosclerosis Family Study (IRAS-FS). J Clin Endocrinol Metab. 2018;103:1877–88.

    Article  PubMed  PubMed Central  Google Scholar 

  15. van der Kolk BW, Vogelzangs N, Jocken JWE, Valsesia A, Hankemeier T, Astrup A, et al. Plasma lipid profiling of tissue-specific insulin resistance in human obesity. Int J Obes. 2019;43:989−98.

  16. Larsen TM, Dalskov S, van Baak M, Jebb S, Kafatos A, Pfeiffer A, et al. The diet, obesity and genes (diogenes) dietary study in eight European countries—a comprehensive design for long-term intervention. Obes Rev. 2010;11:76–91.

    Article  CAS  PubMed  Google Scholar 

  17. Schram MT, Sep SJ, van der Kallen CJ, Dagnelie PC, Koster A, Schaper N, et al. The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur J Epidemiol. 2014;29:439–51.

    Article  PubMed  Google Scholar 

  18. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care. 2007;30:89–94.

    Article  CAS  PubMed  Google Scholar 

  19. Wurtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -omic technologies. Am J Epidemiol. 2017;186:1084–96.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999;15:412–26.

    Article  CAS  PubMed  Google Scholar 

  21. Soeters MR, Sauerwein HP, Faas L, Smeenge M, Duran M, Wanders RJ, et al. Effects of insulin on ketogenesis following fasting in lean and obese men. Obesity. 2009;17:1326–31.

    CAS  PubMed  Google Scholar 

  22. Cobb J, Eckhart A, Perichon R, Wulff J, Mitchell M, Adam KP, et al. A novel test for IGT utilizing metabolite markers of glucose tolerance. J Diabetes Sci Technol. 2015;9:69–76.

    Article  CAS  PubMed  Google Scholar 

  23. Suhre K, Meisinger C, Doring A, Altmaier E, Belcredi P, Gieger C, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One. 2010;5:e13953.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Wurtz P, Makinen VP, Soininen P, Kangas AJ, Tukiainen T, Kettunen J, et al. Metabolic signatures of insulin resistance in 7098 young adults. Diabetes. 2012;61:1372–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Vice E, Privette JD, Hickner RC, Barakat HA. Ketone body metabolism in lean and obese women. Metabolism. 2005;54:1542–5.

    Article  CAS  PubMed  Google Scholar 

  26. Mahendran Y, Vangipurapu J, Cederberg H, Stancakova A, Pihlajamaki J, Soininen P, et al. Association of ketone body levels with hyperglycemia and type 2 diabetes in 9398 Finnish men. Diabetes. 2013;62:3618–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Pietilainen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, Keranen H, et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med. 2008;5:e51.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17:448–53.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376–81.

    Article  CAS  PubMed  Google Scholar 

  31. Mardinoglu A, Gogg S, Lotta LA, Stancakova A, Nerstedt A, Boren J, et al. Elevated plasma levels of 3-hydroxyisobutyric acid are associated with incident type 2 diabetes. EBioMedicine. 2018;27:151–5.

    Article  PubMed  Google Scholar 

  32. Giesbertz P, Daniel H. Branched-chain amino acids as biomarkers in diabetes. Curr Opin Clin Nutr Metab Care. 2016;19:48–54.

    Article  CAS  PubMed  Google Scholar 

  33. Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem. 2010;285:11348–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Lackey DE, Lynch CJ, Olson KC, Mostaedi R, Ali M, Smith WH, et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab. 2013;304:E1175–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab. 2007;293:E1552–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Shimomura Y, Obayashi M, Murakami T, Harris RA. Regulation of branched-chain amino acid catabolism: nutritional and hormonal regulation of activity and expression of the branched-chain alpha-keto acid dehydrogenase kinase. Curr Opin Clin Nutr Metab Care. 2001;4:419–23.

    Article  CAS  PubMed  Google Scholar 

  37. Burrill JS, Long EK, Reilly B, Deng Y, Armitage IM, Scherer PE, et al. Inflammation and ER stress regulate branched-chain amino acid uptake and metabolism in adipocytes. Mol Endocrinol. 2015;29:411–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Badoud F, Lam KP, DiBattista A, Perreault M, Zulyniak MA, Cattrysse B, et al. Serum and adipose tissue amino acid homeostasis in the metabolically healthy obese. J Proteome Res. 2014;13:3455–66.

    Article  CAS  PubMed  Google Scholar 

  39. Saad MJ, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology. 2016;31:283–93.

    Article  CAS  PubMed  Google Scholar 

  40. Wurtz P, Soininen P, Kangas AJ, Ronnemaa T, Lehtimaki T, Kahonen M, et al. Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care. 2013;36:648–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Seibert R, Abbasi F, Hantash FM, Caulfield MP, Reaven G, Kim SH. Relationship between insulin resistance and amino acids in women and men. Physiol Rep. 2015;3:5.

    Article  CAS  Google Scholar 

  42. Adeva-Andany M, Souto-Adeva G, Ameneiros-Rodriguez E, Fernandez-Fernandez C, Donapetry-Garcia C, Dominguez-Montero A. Insulin resistance and glycine metabolism in humans. Amino Acids. 2018;50:11–27.

    Article  CAS  PubMed  Google Scholar 

  43. Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost HG, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62:639–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Sparks JD, Sparks CE, Adeli K. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2012;32:2104–12.

    Article  CAS  PubMed  Google Scholar 

  45. Magkos F, Patterson BW, Mohammed BS, Klein S, Mittendorfer B. Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J Clin Endocrinol Metab. 2007;92:1311–8.

    Article  CAS  PubMed  Google Scholar 

  46. Wang X, Magkos F, Mittendorfer B. Sex differences in lipid and lipoprotein metabolism: it’s not just about sex hormones. J Clin Endocrinol Metab. 2011;96:885–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Muniyappa R, Tella SH, Sortur S, Mszar R, Grewal S, Abel BS, et al. Predictive accuracy of surrogate indices for hepatic and skeletal muscle insulin sensitivity. J Endocr Soc. 2019;3:108–18.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The present study and the work of NV were supported through a grant from the Maastricht University Medical Center+. The Diogenes Study was supported by the European Commission, Food Quality, and Safety Priority of the Sixth Framework Program (FP6-2005-513946). The Maastricht Study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 31O.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), the Cardiovascular Center (CVC, Maastricht, the Netherlands), Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands), School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands), School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands) and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands), and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands). The study sponsors were not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.

Author information

Author notes

  1. These authors contributed equally: Ellen E. Blaak, Ilja C.W. Arts

Authors and Affiliations

  1. Department of Epidemiology, Maastricht University, Maastricht, The Netherlands

    Nicole Vogelzangs, Simone J. P. M. Eussen & Ilja C. W. Arts

  2. Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, The Netherlands

    Nicole Vogelzangs & Ilja C. W. Arts

  3. CARIM School for Cardiovascular Diseases, Maastricht University & Maastricht University Medical Centre, Maastricht, The Netherlands

    Nicole Vogelzangs, Carla J. H. van der Kallen, Marleen M. J. van Greevenbroek, Nicolaas C. Schaper, Ronald M. A. Henry, Simone J. P. M. Eussen, Coen D. A. Stehouwer & Ilja C. W. Arts

  4. Department of Internal Medicine, Maastricht University, Maastricht, The Netherlands

    Carla J. H. van der Kallen, Marleen M. J. van Greevenbroek, Nicolaas C. Schaper, Ronald M. A. Henry & Coen D. A. Stehouwer

  5. Department of Human Biology, Maastricht University, Maastricht, The Netherlands

    Birgitta W. van der Kolk, Johan W. E. Jocken, Gijs H. Goossens, Wim H. M. Saris & Ellen E. Blaak

  6. NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands

    Birgitta W. van der Kolk, Johan W. E. Jocken, Gijs H. Goossens, Wim H. M. Saris & Ellen E. Blaak

  7. CAPHRI School for Care and Public Health Research, Maastricht University, Maastricht, The Netherlands

    Simone J. P. M. Eussen

  8. Nestlé Institute of Health Sciences, Lausanne, Switzerland

    Armand Valsesia

  9. Netherlands Metabolomics Centre, Leiden, The Netherlands

    Thomas Hankemeier

  10. Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

    Arne Astrup

Authors
  1. Nicole Vogelzangs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carla J. H. van der Kallen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marleen M. J. van Greevenbroek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Birgitta W. van der Kolk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Johan W. E. Jocken
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gijs H. Goossens
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nicolaas C. Schaper
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ronald M. A. Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Simone J. P. M. Eussen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Armand Valsesia
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Thomas Hankemeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Arne Astrup
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Wim H. M. Saris
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Coen D. A. Stehouwer
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Ellen E. Blaak
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Ilja C. W. Arts
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the Diogenes consortium

Corresponding author

Correspondence to Nicole Vogelzangs.

Ethics declarations

Conflict of interest

AV is full-time employee at Nestlé Institute of Health Sciences SA. WHMS reports having received research support from several food companies, such as Nestlé, DSM, Unilever, Nutrition et Sante, and Danone as well as Pharmaceutical companies, such as GSK, Novartis, and Novo Nordisk; he is an unpaid scientific advisor for the International Life Science Institute, ILSI Europe. AA reports grants and personal fees from McCain Foods, personal fees from Dutch Beer Knowledge Institute, the Netherlands, personal fees from Gelesis, personal fees from Novo Nordisk, Denmark, outside the submitted work, and royalties received for the book first published in Danish as Verdens Bedste Kur (Politiken; Copenhagen, Denmark), and subsequently published in Dutch as Het beste dieet ter wereld (Kosmos Uitgevers; Utrecht/Antwerpen, the Netherlands), in Spanish as Plan DIOGENES para el control del peso. La dieta personalizada inteligente (Editorial Evergra ́ficas; Léon, Spain), and in English as World’s Best Diet (Penguin, Australia). EEB receives grant support from food industry, such as DSM, Danone, Friesland Campina, Avebe, and Sensus, partly within the context of public–private consortia and has received funding from pharmaceutical companies like Novartis. She is involved in several task forces/expert groups related to the International Life Science Institute, ILSI Europe. All other authors report no possible conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vogelzangs, N., van der Kallen, C.J.H., van Greevenbroek, M.M.J. et al. Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the Diogenes study and the Maastricht Study. Int J Obes 44, 1376–1386 (2020). https://doi.org/10.1038/s41366-020-0565-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-020-0565-z

This article is cited by

Search

Advanced search

Quick links